On March 6, 2018, 23andMe, Inc. received the first-ever FDA authorization for a direct-to-consumer genetic test that analyzes gene mutations... Read More

Cancer cells are characterized by uncontrolled proliferation due to genetic and/or epigenetic changes. The wide scope of such changes poses... Read More

There has been a continuous search for treatment of Parkinson’s disease. Recently, neuroscientist Patrik Verstreken discovered the use of vitamin... Read More

A controversial study of the H5N1 bird flu virus has been published today in the journal Nature. The study, and... Read More

Fanconi anemia, a recessive hereditary disease, leads to dysplasia, degeneration of bone marrow, and an increased risk of leukemia and tumors.... Read More

Stage III and IV melanoma patients are routinely tested for the BRAF gene mutation, a known oncogene for melanoma. Recently,... Read More